Eli Lilly and Company (NYSE:LLY) will release earnings for its first quarter before the opening bell on Thursday, April 30.
Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings of $6.79 per share. That’s up from $3.34 per share in the year-ago period. The consensus estimate for Eli Lilly’s quarterly revenue is $17.8 billion (it reported $12.73 billion last year), according to Benzinga Pro.
As per the recent news, Profluent has entered a multi-program strategic research collaboration with Eli Lilly to develop and commercialize custom site-specific recombinases to treat genetic diseases.
Shares of Eli Lilly fell 2.6% to close at $851.21 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how …
This post was originally published here
